NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 8HSA designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8HSA_NAD_A_401 | 63% | 46% | 0.144 | 0.944 | 0.86 | 1.13 | 1 | 3 | 1 | 0 | 100% | 1 |
| 8HSA_NAD_D_401 | 54% | 45% | 0.16 | 0.929 | 0.89 | 1.11 | 1 | 4 | 1 | 0 | 100% | 1 |
| 8HSA_NAD_F_401 | 47% | 45% | 0.181 | 0.923 | 0.88 | 1.13 | 1 | 4 | 2 | 0 | 100% | 1 |
| 8HSA_NAD_G_401 | 46% | 46% | 0.175 | 0.911 | 0.83 | 1.13 | 1 | 2 | 0 | 0 | 100% | 1 |
| 8HSA_NAD_C_401 | 35% | 43% | 0.215 | 0.909 | 0.87 | 1.21 | - | 5 | 3 | 0 | 100% | 1 |
| 8HSA_NAD_E_401 | 27% | 45% | 0.213 | 0.867 | 0.84 | 1.19 | 1 | 4 | 5 | 0 | 100% | 1 |
| 8HSA_NAD_B_401 | 17% | 44% | 0.253 | 0.839 | 0.88 | 1.17 | 1 | 3 | 2 | 0 | 100% | 1 |
| 8HSA_NAD_H_401 | 3% | 45% | 0.349 | 0.721 | 0.85 | 1.17 | 1 | 3 | 2 | 0 | 100% | 1 |
| 8HS4_NAD_B_401 | 44% | 49% | 0.167 | 0.896 | 0.8 | 1.04 | 1 | 3 | 0 | 0 | 100% | 1 |
| 8HS5_NAD_A_401 | 24% | 53% | 0.226 | 0.862 | 0.8 | 0.9 | 1 | 2 | 2 | 0 | 100% | 1 |
| 3CMC_NAD_R_408 | 100% | 19% | 0.016 | 0.998 | 1.63 | 1.74 | 4 | 9 | 0 | 0 | 100% | 1 |
| 4RQU_NAD_B_403 | 100% | 3% | 0.019 | 0.997 | 3.51 | 2.61 | 13 | 18 | 0 | 0 | 100% | 1 |
| 2O2Y_NAD_D_550 | 100% | 17% | 0.023 | 0.996 | 1.65 | 1.87 | 4 | 9 | 0 | 0 | 100% | 1 |
| 2BJK_NAD_A_1517 | 100% | 55% | 0.025 | 0.995 | 0.72 | 0.86 | - | 1 | 1 | 0 | 100% | 0.86 |
| 3EC7_NAD_A_400 | 100% | 17% | 0.025 | 0.995 | 1.8 | 1.74 | 5 | 8 | 1 | 0 | 100% | 1 |
